NCT03663218 2026-03-18
PREPARE SBRT
Weill Medical College of Cornell University
Phase NA Active not recruiting
Clinical Trials
3,719 trialsNCT04895839 2026-03-18
PC-PEP
Nova Scotia Health Authority
Phase NA Recruiting
NCT05343936 2026-03-18
Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian Population
Hospital Moinhos de Vento
Active not recruiting
NCT05435495 2026-03-18
Mechanisms of Resistance to PSMA Radioligand Therapy
University of California, San Francisco
Recruiting
NCT06408597 2026-03-18
Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy
Cairo University
Phase NA Active not recruiting
NCT07428642 2026-03-18
PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.
First Affiliated Hospital of Wenzhou Medical University
Completed
NCT07480044 2026-03-18
A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological Surgery
Zhejiang University
Phase NA Not yet recruiting
NCT02064673 2026-03-17
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
University of Texas Southwestern Medical Center
Phase 3 Recruiting
NCT02478112 2026-03-17
BioPro-RCMI
Centre Oscar Lambret
Phase NA Terminated
NCT05245006 2026-03-17
PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer
University of California, San Francisco
Phase 1 Active not recruiting
NCT05888532 2026-03-17
64Cu-GRIP B in Patients With Advanced Malignancies
University of California, San Francisco
Phase 1/2 Recruiting
NCT07111507 2026-03-17
A Study of Tarlatamab for People With Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT07398690 2026-03-17
INSIGHT-PCa
Asan Medical Center
Phase NA Recruiting
NCT07476677 2026-03-17
ANDARP
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT07477626 2026-03-17
RADVAN
Sun Yat-sen University
Phase 3 Active not recruiting
NCT07478536 2026-03-17
CHAS3
Insel Gruppe AG, University Hospital Bern
Not yet recruiting
NCT03360721 2026-03-16
Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT04037254 2026-03-16
Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring
NRG Oncology
Phase 1/2 Completed
NCT04190446 2026-03-16
A Study to Evaluate Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer
Mayo Clinic
Phase 2 Active not recruiting
NCT05751941 2026-03-16
Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Recruiting
NCT07245745 2026-03-16
Prospective Clinical Study Comparing PROMS After Adaptive or Conventional Radiotherapy in Prostate Cancer
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase NA Recruiting
NCT07422597 2026-03-16
PRORAND
Norwegian University of Science and Technology
Phase NA Recruiting
NCT07468838 2026-03-16
UroDNA
Institut Cancerologie de l'Ouest
Not yet recruiting
NCT07474142 2026-03-16
PSMA-VISION
Xijing Hospital
Recruiting
NCT07475533 2026-03-16
Low-flow Versus Minimal-flow Sevoflurane Anesthesia During Robot-assisted Laparoscopic Radical Prostatectomy
Ankara City Hospital Bilkent
Phase NA Not yet recruiting
NCT01596816 2026-03-13
CKNO-PRO
Centre Oscar Lambret
Phase 2 Completed
NCT03652298 2026-03-13
NeuroPrevPTSD
Centre Oscar Lambret
Phase 2 Terminated
NCT04624256 2026-03-13
GARUDA
Jonsson Comprehensive Cancer Center
Phase NA Active not recruiting
NCT04788277 2026-03-13
Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)
Thomas Jefferson University
Recruiting
NCT04857502 2026-03-13
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT06173362 2026-03-13
Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer
University of California, Davis
Phase 2 Recruiting
NCT06288113 2026-03-13
Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial
Jonsson Comprehensive Cancer Center
Phase 2 Recruiting
NCT07025369 2026-03-13
Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
Mayo Clinic
Phase 2 Recruiting
NCT07335796 2026-03-13
A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT07463092 2026-03-13
Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy
University of Sao Paulo
Phase NA Not yet recruiting
NCT07468903 2026-03-13
Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
Jonsson Comprehensive Cancer Center
Phase NA Not yet recruiting
NCT01804712 2026-03-12
Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy
University of California, San Diego
Phase EARLY_PHASE1 Completed
NCT05918263 2026-03-12
Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE Trial
Dana-Farber Cancer Institute
Phase NA Active not recruiting
NCT05960578 2026-03-12
Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study
University of Washington
Phase 2 Active not recruiting
NCT06523634 2026-03-12
STEREOBED
Jules Bordet Institute
Phase NA Recruiting
NCT06561230 2026-03-12
Leveraging EA8191 to Assess AI-Augmented EHR Abstraction
University of Pennsylvania
Active not recruiting
NCT07296887 2026-03-12
CARE Tool Study Aim 3
Washington University School of Medicine
Phase NA Not yet recruiting
NCT07460843 2026-03-12
Comparison of TB+PB and TB+6SB for Prostate Cancer Diagnosis
Peking University First Hospital
Phase NA Recruiting
NCT03424850 2026-03-11
Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy
Washington University School of Medicine
Phase 1/2 Recruiting
NCT06040125 2026-03-11
Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial
Dana-Farber Cancer Institute
Phase NA Recruiting
NCT06437574 2026-03-11
Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer
Cedars-Sinai Medical Center
Phase 2 Recruiting
NCT06542757 2026-03-11
Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided Radiotherapy
NYU Langone Health
Phase NA Recruiting
NCT07090148 2026-03-11
Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC
University of Wisconsin, Madison
Phase 1 Recruiting
NCT07441837 2026-03-11
TeLuNa
Ankara University
Phase 2 Not yet recruiting
NCT07463833 2026-03-11
Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
UNC Lineberger Comprehensive Cancer Center
Phase NA Not yet recruiting